Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Alimera Sciences (ALIM) News Today

Alimera Sciences logo

ALIM Latest News

Alimera Sciences Inc.
ANI Pharmaceuticals’ Record Growth and Strategic Acquisition
Alimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven?
Alimera Sciences, Inc. (ALIM)
Alimera Sciences Shares Slide on Merger Lawsuit
Alimera Sciences Reports Second Quarter 2024 Results
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
Robust Growth and Promising Trials: Buy Rating for Alimera Sciences
Alimera Sciences Reports First Quarter 2024 Results
Luckie & Company Acquires Marbury Creative Group
Luckie & Co. acquires Atlanta marketing agency
Q4 2023 Alimera Sciences Inc Earnings Call
A Preview Of Alimera Sciences's Earnings
Get Alimera Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALIM Media Mentions By Week

ALIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALIM
News Sentiment

0.00

0.50

Average
Medical
News Sentiment

ALIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALIM Articles
This Week

0

1

ALIM Articles
Average Week

Get the Latest News and Ratings for ALIM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alimera Sciences and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:ALIM) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners